IRIS
VETTORI, Serena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.623
NA - Nord America 1.559
AS - Asia 631
SA - Sud America 111
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.937
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.518
IE - Irlanda 492
HK - Hong Kong 240
UA - Ucraina 210
GB - Regno Unito 192
DE - Germania 168
FR - Francia 167
SG - Singapore 166
IT - Italia 161
CN - Cina 119
BR - Brasile 98
TR - Turchia 73
GR - Grecia 67
FI - Finlandia 61
SE - Svezia 48
CA - Canada 33
BE - Belgio 30
VN - Vietnam 7
AT - Austria 6
AR - Argentina 5
EU - Europa 4
IN - India 4
RU - Federazione Russa 4
ZA - Sudafrica 4
CH - Svizzera 3
EC - Ecuador 3
HR - Croazia 3
KR - Corea 3
NL - Olanda 3
PK - Pakistan 3
VE - Venezuela 3
BY - Bielorussia 2
CU - Cuba 2
ES - Italia 2
HU - Ungheria 2
ID - Indonesia 2
IQ - Iraq 2
IR - Iran 2
KZ - Kazakistan 2
MA - Marocco 2
PE - Perù 2
TH - Thailandia 2
TN - Tunisia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
LT - Lituania 1
MX - Messico 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 3.937
Salva come PNG Salva come JPEG
Città #
Dublin 491
Jacksonville 360
Santa Clara 321
Hong Kong 236
Chandler 124
Singapore 80
Bremen 77
Princeton 75
Ann Arbor 73
Beijing 62
Medford 60
Roxbury 55
Wilmington 38
Woodbridge 35
Brussels 30
Caserta 28
Des Moines 28
Ottawa 25
Boardman 23
Cambridge 21
San Mateo 20
Mountain View 15
Napoli 13
Helsinki 10
Falls Church 9
Ashburn 8
New York 8
Auburn Hills 7
Düsseldorf 7
Fiano Romano 7
Jinan 7
Nanjing 7
Nuremberg 7
Dong Ket 6
Falkenstein 6
Guangzhou 6
Hanover 6
Los Angeles 6
Hefei 5
Montréal 5
Naples 5
Brasília 4
Hebei 4
Ningbo 4
Norwalk 4
Seattle 4
São Paulo 4
Houston 3
Johannesburg 3
Mcallen 3
Milan 3
Munich 3
Nanchang 3
Seoul 3
Uberaba 3
Vienna 3
Almaty 2
Anzio 2
Arapiraca 2
Baghdad 2
Bauru 2
Belo Horizonte 2
Berlin 2
Callao 2
Casablanca 2
Casalnuovo Di Napoli 2
Cedar Knolls 2
Central District 2
Chene-bourg 2
Criciúma 2
Fortaleza 2
Francisco Morato 2
Guayaquil 2
Gunzenhausen 2
Hangzhou 2
Hatfield 2
Havana 2
Kunming 2
Lainate 2
Natal 2
North Bergen 2
Pescara 2
Porto Alegre 2
Praia Grande 2
Rio de Janeiro 2
Shenyang 2
Sorocaba 2
São Bernardo do Campo 2
Taiyuan 2
Tappahannock 2
Toronto 2
Torre Annunziata 2
Torre del Greco 2
Varese 2
Alfenas 1
Ambato 1
Amsterdam 1
Antakya 1
Anápolis 1
Araraquara 1
Totale 2.545
Salva come PNG Salva come JPEG
Nome #
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 100
Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment. 92
Early Systemic Sclerosis: Marker Autoantibody Positive Patients Have A Faster Pace Of The Disease. 91
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency 89
Clinical correlates of human leukocyte antigen-G (HLA-G) in systemic sclerosis. 88
Early systemic sclerosis: Analysis of the disease course in patients with marker autoantibody or capillaroscopic positivity or both. 87
CLINICAL AND SUBCLINICAL ATHEROSCLEROSIS IN SYSTEMIC SCLEROSIS (SSC) PATIENTS 86
Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey 79
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research 77
CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc) 76
Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers. 69
[Survival and death causes in 251 systemic sclerosis patients from a single Italian center]. 67
Tissue Doppler imaging in systemic sclerosis: A 3-year longitudinal study. 66
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis. 65
Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features 64
High IL-17E and Low IL-17C Dermal Expression Identifies a Fibrosis-Specific Motif Common to Morphea and Systemic Sclerosis. 63
Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels. 63
Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders. 60
Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study 60
European Scleroderma Study Group (ESCSG) Activity Index is correlated to quality of life measures both at admission and overtime 60
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: Derivation and validation of a preliminarily revised EUSTAR activity index 60
Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy 59
Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis 59
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis 59
CARDIAC BLOCKS IN SYSTEMIC SCLEROSIS: PREVALENCE AND ASSOCIATED FEATURES IN THE EUSTAR COHORT 58
Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease. 57
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group 57
[Hypocomplementemia in systemic sclerosis]. 56
Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression 56
Peripheral blood mononuclear cells (PBMCs) of systemic sclerosis patients induce apoptosis in cocultured autologous fibroblasts and up-regulate HLA-DR and FASL 55
CROSS-SECTIONAL EVALUATION OF CHEMOKINE PROFILE IN EARLY AND DEFINITE SYSTEMIC SCLEROSIS 54
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database 54
Functional changes in scleroderma fibroblasts co-cultured with autologous peripheral blood mononuclear cells (PBMCS) 53
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 53
Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role? 51
Serum CXCL4 Increase in Patients with Undifferentiated Connective Tissue Disease at Risk for Systemic Sclerosis Is Associated with Anti-Scl70 Antibodies and ICAM-1, a Marker of Endothelial Activation 51
The Concept of Early Systemic Sclerosis Following 2013 ACR\EULAR Criteria for the Classification of Systemic Sclerosis. 48
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 48
Early systemic sclerosis: short –term disease evolution and factors predidting the development of new manifestations of organ involvement 48
Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases 48
SAT0181 CXCL4 Is Not A Biomarker in Rheumatoid Arthritis Patients Treated with Abatacept and Tocilizumab 48
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 48
Identification of a New Set of Activity Criteria for Systemic Sclerosis. Preliminary Report 47
Outcome of a glucocorticoid discontinuation regimen in patients with inactive systemic sclerosis 47
Peripheral Blood Mononuclear Cells Co-Cultured With Autologous Skin Fibroblasts Up-Regulate IL-17A and Play Anti-Fibrotic Effects In Systemic Sclerosis. 46
SURNATANTS FROM SYSTEMIC SCLEROSIS PBMCS CO-CULTURED WITH AUTOLOGOUS FIBROBLASTS DISPLAY HIGH LEVELS OF PRO-FIBROTIC CYTOKINES 46
Role of microRNAs in fibrosis 46
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 46
Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review 45
The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: A validation study of the NEMO score 44
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database 43
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database 43
FRI0522 Peripheral Blood Mononuclear Cells Co-Cultured with Autologous Skin Fibroblasts Up-Regulate IL-17A and Play Anti-Fibrotic Effects in Systemic Sclerosis 43
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis 43
MiRs in RA: possible biomarkers and therapeutic targets 43
Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: A longitudinal EUSTAR study 42
T-Cell Proapoptotic and Antifibrotic Activity Against Autologous Skin Fibroblasts in vitro Is Associated With IL-17A Axis Upregulation in Systemic Sclerosis 42
IL-22 capacitates dermal fibroblast responses to TNF in scleroderma 41
Serum CXCL4 increase in primary Sjögren’s syndrome characterizes patients with microvascular involvement and reduced salivary gland infiltration and lymph node involvement 41
Mapping and predicting mortality from systemic sclerosis 41
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease 41
The β-fibrinogen -455 G>A gene polymorphism is associated with peripheral vascular injury in systemic sclerosis patients 39
Hypocomplementemia in Systemic sclerosis - Author reply 38
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosis 38
Phenotypes determined by cluster analysis and their survival in the prospective EUSTAR cohort of patients with systemic sclerosis 38
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 38
Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value 37
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 37
Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database 36
FRI0446 Severe Heart Disease in Systemic Sclerosis: Prevalence, Risk Factors and Current Treatment. A Eustar-Desscipher Study 35
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study 35
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database 34
Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis 34
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study 33
Hemodynamic changes after acute fluid loading in patients with systemic sclerosis without pulmonary hypertension 30
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database 29
Fulminant Myocarditis Unmasking Adult-Onset Still's Disease and Desmoplakin Truncation 28
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort 28
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 11
Progression, Management, and Outcome of Aortic Valve Stenosis in Systemic Sclerosis: A Case Series 10
Totale 4.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.528
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 0 0 0 0 0 0 0 0 57 37 27 7
2020/2021446 29 6 58 17 59 4 78 50 8 46 72 19
2021/2022495 28 5 11 25 175 6 14 7 14 32 39 139
2022/2023809 99 56 5 29 103 38 3 28 413 7 8 20
2023/2024326 27 15 8 23 121 11 3 9 1 23 26 59
2024/2025845 6 8 0 15 187 199 238 79 113 0 0 0
Totale 4.120